Skip to content

Altizide

CARDIOVASCULAR SYSTEM

Also known as: aldactazine, althiazide, althizide, altizid, altizida, racemic althiazide

ATC C03EA04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Altizide is a drug catalogued in DrugCentral. Recorded indications include Edema and Hypertensive disorder.

  • Indications: Edema and Hypertensive disorder.
  • ATC code: C03EA04 (Low-ceiling diuretics and potassium-sparing agents).
  • Molecular formula: C11H14ClN3O4S3; molecular weight 383.88 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Edema
  • Hypertensive disorder

ATC classification

ATC codeTherapeutic hierarchy
C03EA04CARDIOVASCULAR SYSTEM › DIURETICS › DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION › Low-ceiling diuretics and potassium-sparing agents

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Altizide is on its molecule page.

Molecular formulaC11H14ClN3O4S3
Molecular weight383.88 g/mol
CAS number5588-16-9
InChIKeyVGLGVJVUHYTIIU-UHFFFAOYSA-N
PubChem CID2122
NS(=O)(=O)C1=CC2=C(NC(CSCC=C)NS2(=O)=O)C=C1Cl

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Altizide used for?

DrugCentral lists the following indications for Altizide: Edema and Hypertensive disorder.

What is the chemical formula of Altizide?

Altizide has the molecular formula C11H14ClN3O4S3 and a molecular weight of 383.88 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications2
FormulaC11H14ClN3O4S3
DrugCentral ID140
Interactive profile